JBI Evidence Synthesis releases first issue for 2024

The first issue of JBI Evidence Synthesis for 2024 includes a systematic review and meta-analysis, Impact of lifestyle-based interventions on absolute cardiovascular disease risk, which is supplemented by a Spanish-language version of the abstract.

Also included in the first issue for 2024 is an umbrella review, Pharmacological interventions for reducing the incidence of myoclonus in patients receiving etomidate for induction of general anesthesia

Both reviews are accompanied by free access JBI Best Practice Information Sheets which are high-quality, 4-page summaries of a JBI systematic Review that include infographics and recommendations for practice.

Reflecting the multidisciplinary scope of JBI Evidence Synthesis, diverse protocols are published in this issue, including:
 
Health literacy and parenting infants at home: protocol for a qualitative systematic review of parents’ experiences

Cost-effectiveness of a decentralized care model for managing multi-drug-resistant tuberculosis in low- and middle-income countries: a systematic review protocol

Use of administrative claims data in observational studies of antirheumatic medication effects on pregnancy outcomes: a scoping review protocol

Effectiveness of mHealth interventions for improving health attendance: an umbrella review protocol

See the full list of articles in the  table of contents  for the January 2024 issue of JBI Evidence Synthesis (Volume 22, Issue 21).